Log In
BCIQ
Print this Print this
 

ZONK1103

  Manage Alerts
Collapse Summary General Information
Company Zonk Drug R&D Ltd.
Description 
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationIschemia / reperfusion injury
Indication DetailsTreat ischemic heart disease
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today